Palvella Therapeutics, Inc. (NASDAQ:PVLA - Get Free Report) has been given an average rating of "Buy" by the fifteen analysts that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, twelve have issued a buy rating and two have as